Skip to main content
Industry News
Crush-proof OxyContin doesn't seem to have cut OD, death rates

Purdue Pharma said a decade ago its crush-resistant formulation of OxyContin would prevent opioid overdoses and deaths, but while the new formulation might have reduced abuse via injection or snorting, it does not appear to have contributed to fewer deaths or overdoses, according to an FDA panel of experts.

Full Story: